• $36.8M
    Market Cap
  • -20.33%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2026
03/31/2025
03/31/2024
03/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
100.0M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
-100.00%
100.0M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
252,000
-61.88%
661,000
+27.61%
Research and Development Expense
-2.4M
-74.71%
-9.5M
+103.10%
-4.7M
-53.04%
-10.0M
+79.38%
Depreciation and Amortization Expense
7,000
0.00%
7,000
-36.36%
11,000
-91.13%
124,000
N/A
Total Operating Expenses
8.7M
+20.98%
7.2M
+11.44%
6.4M
-15.52%
7.6M
N/A
Operating Profit
-11.1M
-33.59%
-16.7M
+29.78%
-12.9M
-75.36%
-52.2M
+234.56%
Interest Income
685,000
-3.66%
711,000
-21.95%
911,000
+270.33%
246,000
+219.48%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
685,000
-3.66%
711,000
-21.95%
911,000
+270.33%
246,000
+219.48%
Total Nonoperating Income and Expense
1.6M
-59.51%
3.9M
+313.42%
-1.8M
-1,096.20%
184,000
-96.41%
Income before Taxes
-9.5M
-25.64%
-12.8M
-13.06%
-14.7M
-71.74%
-52.0M
+396.52%
Income Taxes
-1.7M
-46.86%
-3.2M
+74.62%
-1.8M
-80.80%
-9.5M
+1,372.53%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.8M
-18.55%
-9.6M
-25.56%
-12.9M
-69.71%
-42.4M
+332.11%
Net Income from Continuing Operations Applicable to Common
-9.5M
-25.64%
-12.8M
-13.06%
-14.7M
-71.74%
-52.0M
+396.52%
Basic EPS and Net Income
-0.47
-40.51%
-0.79
-41.48%
-1.35
+42.11%
-0.95
+251.85%
Diluted EPS and Net Income
-0.47
-40.51%
-0.79
-41.48%
-1.35
+42.11%
-0.95
+251.85%
Basic Weighted Average Shares
16.5M
+36.60%
12.1M
+26.85%
9.5M
-78.64%
44.6M
+21.09%
Diluted Weighted Average Shares
16.5M
+36.60%
12.1M
+26.85%
9.5M
-78.64%
44.6M
+21.09%
Balance Sheet
Cash and Cash Equivalents
17.0M
-23.30%
22.1M
-3.79%
23.0M
-17.47%
27.9M
-8.12%
Short-Term Investments
N/A
N/A
N/A
N/A
0
-100.00%
15,000
-99.89%
Cash and Cash Equivalents and Short-Term Investments
17.0M
-23.30%
22.1M
-3.79%
23.0M
-17.52%
27.9M
-36.12%
Total Current Assets
17.4M
-23.48%
22.7M
-5.41%
24.0M
-18.03%
29.3M
-35.67%
Accumulated Depreciation
0
-100.00%
1,000
-99.84%
608,000
+6.67%
570,000
N/A
Property and Plant and Equipment and Net
8,000
-46.67%
15,000
-37.50%
24,000
-76.92%
104,000
-99.50%
Total Long-Term Assets
0
N/A
0
-100.00%
24,000
-99.80%
12.2M
-64.30%
Total Assets
66.7M
-7.42%
72.0M
-1.78%
73.3M
-7.36%
79.1M
-38.48%
Income Taxes Payable
612,000
-73.53%
2.3M
-58.07%
5.5M
-24.95%
7.3M
-56.50%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.1M
+11.19%
1.9M
+14.61%
1.7M
-50.63%
3.4M
+4.63%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1.2M
-78.77%
5.8M
-62.53%
15.4M
+1.87%
15.1M
-55.55%
Total Liabilities
2.8M
-48.76%
5.4M
-53.42%
11.6M
+3.48%
11.2M
-45.12%
Retained Earnings
-228.5M
+3.53%
-220.7M
+4.53%
-211.1M
+6.48%
-198.3M
+27.23%
Total Stockholders Equity
63.9M
-4.07%
66.6M
+7.88%
61.7M
-9.14%
68.0M
-37.24%
Total Shares Outstanding
16.0M
+16.81%
13.7M
+45.95%
9.4M
-78.93%
44.6M
N/A
Cash Flow
Cash from Operating Activities
-8.9M
-40.49%
-14.9M
+20.85%
-12.3M
-22.50%
-15.9M
-7.67%
Capital Expenditures
N/A
N/A
0
-100.00%
22,000
N/A
N/A
N/A
Cash from Investing Activities
0
N/A
0
-100.00%
104,000
-99.21%
13.2M
+473.45%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
3.7M
-73.54%
14.0M
+90.68%
7.4M
+2,320.72%
304,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-52.15%
N/A
Return on Assets
-11.24%
-14.65%
-13.17%
-21.91%
-16.86%
-58.71%
-40.85%
+297.45%
Return on Equity
-11.94%
-19.90%
-14.91%
-24.78%
-19.82%
-58.84%
-48.15%
+301.96%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
8.10
-31.18%
11.77
-17.46%
14.26
+66.04%
8.59
-38.52%
Cash Ratio
7.91
-31.02%
11.47
-16.05%
13.66
+67.17%
8.17
-12.19%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow